Abstract
Administration of oral contraceptives to 10 women was started two weeks after the normalization of the serum enzyme activities in the convalescent period of viral hepatitis, and to five women eight weeks after an operation of obstructive jaundice. Routine liver function tests were performed at intervals of two weeks for two to three months. The liver function tests stayed within normal limits during the follow-up period.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLERCREUTZ H. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Oct 31;2(5417):1133–1133. [PMC free article] [PubMed] [Google Scholar]
- BOAKE W. C., SCHADE S. G., MORRISSEY J. F., SCHAFFNER F. INTRAHEPATIC CHOLESTATIC JAUNDICE OF PREGNANCY FOLLOWED BY ENOVID-INDUCED CHOLESTATIC JAUNDICE: REPORT OF A CASE. Ann Intern Med. 1965 Aug;63:302–308. doi: 10.7326/0003-4819-63-2-302. [DOI] [PubMed] [Google Scholar]
- Haemmerli U. P., Wyss H. I. Recurrent intrahepatic cholestasis of pregnancy. Report of six cases, and review of the literature. Medicine (Baltimore) 1967 Jul;46(4):299–321. doi: 10.1097/00005792-196707000-00001. [DOI] [PubMed] [Google Scholar]
- LARSSON-COHN U., STENRAM U. JAUNDICE DURING TREATMENT WITH ORAL CONTRACEPTIVE AGENTS: REPORT OF TWO CASES. JAMA. 1965 Aug 9;193:422–426. doi: 10.1001/jama.1965.03090060012002. [DOI] [PubMed] [Google Scholar]